The DOI matches its Crossref record; 138 of the 138 references it cites were found in a registry or an index.
Nanotechnology for protein delivery: Overview and perspectives
Open accessAbstract
Protein-based therapeutics have made a significant impact in the treatment of a variety of important human diseases. However, given their intrinsically vulnerable structure and susceptibility to enzymatic degradation, many therapeutic proteins such as enzymes, growth factors, hormones, and cytokines suffer from poor physicochemical/biological stability and immunogenicity that may limit their potential benefits, and in some cases limit their utility. Furthermore, when protein therapeutics are developed for intracellular targets, their internalization and biological activity may be limited by inefficient membrane permeability and/or endosomal escape. Development of effective protein delivery strategies is therefore essential to further enhance therapeutic outcomes to enable widespread medical applications. This review discusses the advantages and limitations of marketed and developmental-stage protein delivery strategies, and provides a focused overview of recent advances in nanotechnology platforms for the systemic delivery of therapeutic proteins. In addition, we also highlight nanoparticle-mediated non-invasive administration approaches (e.g., oral, nasal, pulmonary, and transdermal routes) for protein delivery.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Delivery of proteins such as catalase raises a few concerns such as its instability in vivo due to the presence of numerous physiological proteases, unpredictable protein immunogenicity, and poor in vivo half-life.27,28”
From Catalase-Integrated Hyaluronic Acid as Nanocarriers for Enhanced Photodynamic Therapy in Solid Tumor (2019) · cites this paper as [27]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nanocarriers as an emerging platform for cancer therapy
Peer, D., Karp, J. M., Hong, S., Farokhzad, O. C., Margalit, R., & Langer, R. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.387 · Cited by 8,710
Self-citationPushko, P., Pumpens, P., & Grens, E. (2013) · Intervirology · doi:10.1159/000346773 · Cited by 5,975
Recent advances with liposomes as pharmaceutical carriers
Torchilin, V. P. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1632 · Cited by 5,282
Cancer immunotherapy comes of age
Mellman, I., Coukos, G., & Dranoff, G. (2011) · Nature · doi:10.1038/nature10673 · Cited by 3,893
Prausnitz, M. R., & Langer, R. (2008) · Nature Biotechnology · doi:10.1038/nbt.1504 · Cited by 3,691
Biodegradable Long-Circulating Polymeric Nanospheres
Gref, R., Minamitake, Y., Peracchia, M. T., Trubetskoy, V. S., Torchilin, V. P., & Langer, R. (1994) · Science · doi:10.1126/science.8128245 · Cited by 2,951
Bertrand, N., Wu, J., Xu, X., Kamaly, N., & Farokhzad, O. C. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.11.009 · Cited by 2,925
Self-citationGold nanoparticles in nanomedicine: preparations, imaging, diagnostics, therapies and toxicity
Boisselier, É., & Astruc, D. (2009) · Chemical Society Reviews · doi:10.1039/b806051g · Cited by 2,832
Nanoparticles in Medicine: Therapeutic Applications and Developments
Zhang, L., Gu, F., Chan, J. M., Wang, A. Z., Langer, R., & Farokhzad, O. C. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100400 · Cited by 2,685
Self-citationPolymeric systems for controlled drug release
Uhrich, K. E., Cannizzaro, S. M., Langer, R. S., & Shakesheff, K. M. (1999) · Chemical Reviews · doi:10.1021/cr940351u · Cited by 2,633
Flagged first, then by citations
Cited by
Sorted by citations
Cancer nanomedicine: progress, challenges and opportunities
Shi, J., Kantoff, P. W., Wooster, R., & Farokhzad, O. C. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2016.108 · Cited by 5,873
Self-citationEngineered biomaterials for in situ tissue regeneration
Gaharwar, A. K., Singh, I., & Khademhosseini, A. (2020) · Nature Reviews Materials · doi:10.1038/s41578-020-0209-x · Cited by 892
Toward Nanotechnology-Enabled Approaches against the COVID-19 Pandemic
Weiß, C., Carrière, M., Fusco, L., Capua, I., Regla-Nava, J. Á., Pasquali, M., Scott, J. A., Vitale, F., Ünal, M. A., Mattevi, C., et al. (2020) · ACS Nano · doi:10.1021/acsnano.0c03697 · Cited by 605
Catalase-Integrated Hyaluronic Acid as Nanocarriers for Enhanced Photodynamic Therapy in Solid Tumor
Phua, S. Z. F., Yang, G., Lim, W. Q., Verma, A., Chen, H., Thanabalu, T., & Zhao, Y. (2019) · ACS Nano · doi:10.1021/acsnano.9b01087 · Cited by 375
Cheng, G., Li, W., Ha, L., Han, X., Hao, S., Wan, Y., Wang, Z., Dong, F., Zou, X., Mao, Y., et al. (2018) · Journal of the American Chemical Society · doi:10.1021/jacs.8b03584 · Cited by 371
Metal-Organic Framework (MOF)-Based Drug Delivery
Cao, J., Li, X., & Tian, H. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867326666190618152518 · Cited by 281
Rational Design of Nanocarriers for Intracellular Protein Delivery
Qin, X., Yu, C., Wei, J., Li, L., Zhang, C., Wu, Q., Liu, J., Yao, S. Q., & Huang, W. (2019) · Advanced Materials · doi:10.1002/adma.201902791 · Cited by 286
Pramanik, P. K. D., Solanki, A., Debnath, A., Nayyar, A., El–Sappagh, S., & Kwak, K. S. (2020) · IEEE Access · doi:10.1109/access.2020.2984269 · Cited by 224
Iqbal, S., Blenner, M., Alexander-Bryant, A. A., & Larsen, J. (2020) · Biomacromolecules · doi:10.1021/acs.biomac.9b01754 · Cited by 194
Zhang, Q. R., Zhou, Y., Yue, W., Qin, W., Dong, H., & Vasanthan, T. (2021) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2021.01.026 · Cited by 190
Shan, W., Zhu, X. D., Tao, W., Cui, Y., Liu, M., Wu, L., Li, L., Zheng, Y., & Huang, Y. (2016) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b08183 · Cited by 181
Liposome-based delivery of biological drugs
Magar, K. T., Boafo, G. F., Li, X., Chen, Z., & He, W. (2021) · Chinese Chemical Letters · doi:10.1016/j.cclet.2021.08.020 · Cited by 189
Recent advances in colon drug delivery systems
Arévalo-Pérez, R., Maderuelo, C., & Lanao, J. M. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.09.026 · Cited by 179
Nanoparticle‐Mediated Delivery of Inhaled Immunotherapeutics for Treating Lung Metastasis
Jin, Q., Zhu, W., Zhu, J., Zhu, J., Shen, J., Liu, Z., Yang, Y., & Chen, Q. (2021) · Advanced Materials · doi:10.1002/adma.202007557 · Cited by 170
Abbina, S., Vappala, S., Kumar, P., Siren, E. M. J., La, C. C., Abbasi, U., Brooks, D. E., & Kizhakkedathu, J. N. (2017) · Journal of Materials Chemistry B · doi:10.1039/c7tb02515g · Cited by 165
Wu, J., Zheng, Y., Liu, M., Shan, W., Zhang, Z., & Huang, Y. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b16524 · Cited by 155
Self-citationOvercoming Physiological Barriers to Nanoparticle Delivery—Are We There Yet?
Thomas, O. S., & Weber, W. (2019) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2019.00415 · Cited by 146
Poly(lactic acid)/poly(lactic-co-glycolic acid) particulate carriers for pulmonary drug delivery
Emami, F., Yazdi, S. J. M., & Na, D. H. (2019) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-019-00443-1 · Cited by 133
Polymer-based nanoparticles for protein delivery: design, strategies and applications
Zhao, H., Lin, Z. Y., Yildirimer, L., Dhinakar, A., Zhao, X., & Wu, J. (2016) · Journal of Materials Chemistry B · doi:10.1039/c6tb00308g · Cited by 128
Self-citationSilica nanoparticles: A promising platform for enhanced oral delivery of macromolecules
Abeer, M. M., Rewatkar, P. V., Qu, Z., Talekar, M., Kleitz, F., Schmid, R., Lindén, M., Kumeria, T., & Popat, A. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.07.021 · Cited by 125
Chen, J., Ouyang, J., Chen, Q., Deng, C., Meng, F., Zhang, J., Cheng, R., Lan, Q., & Zhong, Z. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b06879 · Cited by 124
Hollow Nanomaterials in Advanced Drug Delivery Systems: From Single‐ to Multiple Shells
Li, Z., Xu, K., Qin, L., Zhao, D., Yang, N., Wang, D., & Yang, Y. (2022) · Advanced Materials · doi:10.1002/adma.202203890 · Cited by 126
Nexus between in silico and in vivo models to enhance clinical translation of nanomedicine
Moradi Kashkooli, F., Soltani, M., Souri, M., Meaney, C., & Kohandel, M. (2021) · Nano Today · doi:10.1016/j.nantod.2020.101057 · Cited by 120
Kim, M., Sahu, A., Hwang, Y.-M., Kim, G. B., Nam, G., Kim, I., Kwon, I. C., & Tae, G. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119550 · Cited by 120
Polymersome-based protein drug delivery – quo vadis?
Gouveia, M. G., Wesseler, J. P., Ramaekers, J., Weder, C., Scholten, P. B. V., & Bruns, N. (2022) · Chemical Society Reviews · doi:10.1039/d2cs00106c · Cited by 119
Applications of nanogenerators for biomedical engineering and healthcare systems
Wang, W., Pang, J., Su, J., Li, F., Li, Q., Wang, X., Wang, J., Ibarlucea, B., Liu, X., Li, Y., et al. (2021) · InfoMat · doi:10.1002/inf2.12262 · Cited by 119
Advances in nanoparticle-mediated cancer therapeutics: Current research and future perspectives
Deivayanai, V. C., Thamarai, P., Karishma, S., Saravanan, A., Yaashikaa, P. R., Vickram, A. S., Hemavathy, R. V., Kumar, R. R., Rishikesavan, S., & Shruthi, S. (2024) · Cancer Pathogenesis and Therapy · doi:10.1016/j.cpt.2024.11.002 · Cited by 124
Song, Z., Chen, X., You, X., Huang, K., Dhinakar, A., Gu, Z., & Wu, J. (2017) · Biomaterials Science · doi:10.1039/c7bm00730b · Cited by 113
Self-citationHe, H., Chen, Y., Li, Y., Song, Z., Zhong, Y., Zhu, R., Cheng, J., & Yin, L. (2018) · Advanced Functional Materials · doi:10.1002/adfm.201706710 · Cited by 111
Nanoparticles as carriers of proteins, peptides and other therapeutic molecules
Pudlarz, A. M., & Szemraj, J. (2018) · Open Life Sciences · doi:10.1515/biol-2018-0035 · Cited by 108
Ding, L., Jiang, Y., Zhang, J., Klok, H., & Zhong, Z. (2017) · Biomacromolecules · doi:10.1021/acs.biomac.7b01664 · Cited by 106
Potential and Applications of Nanocarriers for Efficient Delivery of Biopharmaceuticals
Zeb, A., Rana, I., Choi, H.-I., Lee, C., Baek, S.-W., Lim, C.-W., Khan, N., Arif, S. T., Sahar, N.-U., Alvi, A. M., et al. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12121184 · Cited by 106
Chen, J., Zou, Y., Deng, C., Meng, F., Zhang, J., & Zhong, Z. (2016) · Chemistry of Materials · doi:10.1021/acs.chemmater.6b04404 · Cited by 100
The therapeutic importance of acid-base balance
Quade, B. N., Parker, M. D., & Occhipinti, R. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.114278 · Cited by 108
Deprey, K. L., Becker, L., Kritzer, J. A., & Plückthun, A. (2019) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.9b00112 · Cited by 97
Sifniotis, V., Cruz, E., Eroglu, B., & Kayser, V. (2019) · Antibodies · doi:10.3390/antib8020036 · Cited by 99
Glucagon-Like Peptide-1 Receptor Agonists and Strategies To Improve Their Efficiency
Alavi, S. E., Cabot, P. J., & Moyle, P. M. (2019) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.9b00308 · Cited by 100
Recent progress in polymeric non-invasive insulin delivery
Sabbagh, F., Muhamad, I. I., Niazmand, R., Dikshit, P. K., & Kim, B. S. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.01.134 · Cited by 96
Bioperspectives for Shape-Memory Polymers as Shape Programmable, Active Materials
Lendlein, A., Balk, M., Tarazona, N. A., & Gould, O. E. C. (2019) · Biomacromolecules · doi:10.1021/acs.biomac.9b01074 · Cited by 93
Zai, W., Kang, L., Dong, T., Wang, H., Yin, L., Gan, S., Lai, W., Ding, Y., Hu, Y., & Wu, J. (2021) · ACS Nano · doi:10.1021/acsnano.1c07621 · Cited by 97
Self-citationWu, W., Jia, S., Xu, H., Gao, Z., Wang, Z., Lu, B., Ai, Y., Liu, Y., Liu, R., Yang, T., et al. (2023) · ACS Nano · doi:10.1021/acsnano.2c12017 · Cited by 94
Allawadhi, P., Singh, V., Govindaraj, K., Khurana, I., Sarode, L. P., Navik, U., Banothu, A. K., Weiskirchen, R., Bharani, K. K., & Khurana, A. (2021) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2021.118923 · Cited by 90
Sundaram, M. N., Kaliannagounder, V. K., Selvaprithiviraj, V., Suresh, M. K., Biswas, R., Vasudevan, A. K., Varma, P. K., & Jayakumar, R. (2018) · ACS Sustainable Chemistry & Engineering · doi:10.1021/acssuschemeng.8b00915 · Cited by 88
Nano and microscale delivery platforms for enhanced oral peptide/protein bioavailability
Tong, T., Wang, L., You, X., & Wu, J. (2020) · Biomaterials Science · doi:10.1039/d0bm01151g · Cited by 89
Self-citationLi, Y., Yang, T., Yu, Y., Shi, N., Yang, L., Glass, Z., Bolinger, J., Finkel, I. J., Li, W., & Xu, Q. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.03.011 · Cited by 85
Peng, J., Fumoto, S., Suga, T., Miyamoto, H., Kuroda, N., Kawakami, S., & Nishida, K. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.03.021 · Cited by 83
Gonella, A., Grizot, S., Liu, F., Noriega, A. L., & Richard, J. (2022) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2022.2105318 · Cited by 82
Faustino, C. M. C., Rijo, P. M., & Reis, C. P. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.03.020 · Cited by 82
Oral delivery of antioxidant enzymes for effective treatment of inflammatory disease
Zeng, Z., He, X. D., Li, C., Lin, S., Chen, H., Liu, L., & Feng, X. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.120753 · Cited by 82
Tumor immune microenvironment modulation-based drug delivery strategies for cancer immunotherapy
Han, S., Huang, K., Gu, Z., & Wu, J. (2019) · Nanoscale · doi:10.1039/c9nr08086d · Cited by 85
Self-citationWu, D., Zhou, J., Chen, X., Chen, Y., Hou, S., Qian, H., Zhang, L., Tang, G., Chen, Z., Yuan, P., et al. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.119847 · Cited by 79
Recent Advances of Poly(ester amide)s-Based Biomaterials
Han, S., & Wu, J. (2022) · Biomacromolecules · doi:10.1021/acs.biomac.2c00150 · Cited by 78
Self-citationRole of nanostructures in improvising oral medicine
Ghosh, S., Ghosh, S., & Sil, P. C. (2019) · Toxicology Reports · doi:10.1016/j.toxrep.2019.04.004 · Cited by 78
Rashidzadeh, H., Danafar, H., Rahimi, H., Mozafari, F., Salehiabar, M., Rahmati, M.-A., Rahamouz-Haghighi, S., Mousazadeh, N., Mohammadi, A., Ertaş, Y. N., et al. (2021) · Nanomedicine · doi:10.2217/nnm-2020-0441 · Cited by 77
Oral insulin delivery by epithelium microenvironment-adaptive nanoparticles
Li, J., Qiang, H., Yang, W., Xu, Y., Feng, T., Cai, H., Wang, S., Liu, Z., Zhang, Z., & Zhang, J. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.11.020 · Cited by 77
Araújo, F., Shrestha, N., Gomes, M. J., Herranz‐Blanco, B., Liu, D., Hirvonen, J. J., Granja, P. L., Santos, H. A., & Sarmento, B. F. C. C. (2016) · Nanoscale · doi:10.1039/c6nr00294c · Cited by 77
Wang, X., Li, Y., Li, Q., Neufeld, C. I., Pouli, D., Sun, S., Yang, L., Deng, P. J., Wang, M., Georgakoudi, I., et al. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.01.037 · Cited by 74
Sarıyer, S., Duranoğlu, D., Doğan, Ö., & Küçük, İ. (2020) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2020.101551 · Cited by 73
Bukhari, S. N. A. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14040866 · Cited by 74
Batista, P., Castro, P. M., Madureira, A. R., Sarmento, B. F. C. C., & Pintado, M. (2019) · Pharmaceuticals · doi:10.3390/ph12010032 · Cited by 73
Yang, S., Liu, L., Chen, H., Wei, Y., Dai, L., Liu, J., Yuan, F., Mao, L., Li, Z., Chen, F., et al. (2020) · Food Hydrocolloids · doi:10.1016/j.foodhyd.2020.106258 · Cited by 70
Glucose-responsive oral insulin delivery platform for one treatment a day in diabetes
Xiao, Y., Tang, Z., Huang, X., Joseph, J., Chen, W., Chuang, L. I. U., Zhou, J. M., Kong, N., Joshi, N., Du, J., et al. (2021) · Matter · doi:10.1016/j.matt.2021.08.011 · Cited by 71
Protein Nanotherapeutics as an Emerging Modality for Cancer Therapy
Cheng, L., Yang, L., Meng, F., & Zhong, Z. (2018) · Advanced Healthcare Materials · doi:10.1002/adhm.201800685 · Cited by 68
Sustained Release Systems for Delivery of Therapeutic Peptide/Protein
Nie, T., Wang, W., Liu, X., Wang, Y., Li, K., Song, X., Zhang, J., Yu, L., & He, Z. (2021) · Biomacromolecules · doi:10.1021/acs.biomac.1c00160 · Cited by 68
Nanocarriers for oral delivery of biologics: small carriers for big payloads
Cao, Y., Rewatkar, P. V., Wang, R., Hasnain, S. Z., Popat, A., & Kumeria, T. (2021) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2021.08.005 · Cited by 68
Scaling nanopharmaceutical production for personalized medicine: challenges and strategies
Delfino, C. D. S. C., PEREIRA, M. C. D. P., Oliveira, M., Favareto, I. D. C., Valladão, V. S., Mota, M. D. O., Costa, M. V. B., Sousa-Batista, A. J., & Balbino, T. A. (2025) · Journal of Nanoparticle Research · doi:10.1007/s11051-025-06293-3 · Cited by 68
Protein delivery to the back of the eye: barriers, carriers and stability of anti-VEGF proteins
Radhakrishnan, K., Nirmal, S., Moreno, M. R., Nirmal, J., Fernandez, A. A., Venkatraman, S. S., & Agrawal, R. V. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2016.10.015 · Cited by 66
Rhaman, M. M., Islam, M. R., Akash, S., Mim, M., Noor alam, M., Nepovimova, E., Valis, M., Kuca, K., & Sharma, R. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.989471 · Cited by 63
Nanomaterials for Protein Delivery in Anticancer Applications
Yau, A., Lee, J., & Chen, Y. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13020155 · Cited by 64
Shen, J., Ma, M., Shafiq, M., Yu, H., Lan, Z., & Chen, H. (2022) · Angewandte Chemie International Edition · doi:10.1002/anie.202113703 · Cited by 62
Huang, K., He, Y., Zhu, Z., Guo, J., Wang, G., Deng, C., & Zhong, Z. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b05827 · Cited by 62
Basak, S., Khare, H. A., Roursgaard, M., Kempen, P. J., Lee, J., Bazban‐Shotorbani, S., Kræmer, M. K., Chernyy, S., Andresen, T. L., Almdal, K., et al. (2020) · Biomacromolecules · doi:10.1021/acs.biomac.0c01238 · Cited by 61
Liu, W., Su, C., Qi, Y., Liang, J., Zhao, L., & Shi, Y. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01425-6 · Cited by 62
The Potential Benefits of Nanotechnology in Treating Alzheimer’s Disease
Ling, T. S., Chandrasegaran, S., Low, Z. X., Suan, T. L., Elaine, E., Nathan, D. V., Chai, Y. H., Gunasekaran, B., & Salvamani, S. (2021) · BioMed Research International · doi:10.1155/2021/5550938 · Cited by 61
Approaches and materials for endocytosis-independent intracellular delivery of proteins
Chen, N., He, Y., Zang, M., Zhang, Y., Lü, H., Zhao, Q., Wang, S., & Gao, Y. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121567 · Cited by 59
Bioorthogonal strategies for site-directed decoration of biomaterials with therapeutic proteins
Braun, A. C., Gutmann, M., Lühmann, T. C., & Meinel, L. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.01.018 · Cited by 57
Zwitterionic Janus Dendrimer with distinct functional disparity for enhanced protein delivery
Wang, L., Shi, C., Wang, X., Guo, D., Duncan, T. M., & Luo, J. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119233 · Cited by 55
Zhang, Z., Chen, K., Ameduri, B. M., & Chen, M. (2023) · Chemical Reviews · doi:10.1021/acs.chemrev.3c00350 · Cited by 56
Zhu, X., Tang, R., Wang, S., Chen, X., Hu, J., Lei, C., Huang, Y., Wang, H., Nie, Z., & Yao, S. (2020) · ACS Nano · doi:10.1021/acsnano.9b09024 · Cited by 55
Nanotraps for the containment and clearance of SARS-CoV-2
Chen, M., Rosenberg, J. N., Cai, X., Lee, A. C. H., Shi, J., Nguyen, M., Wignakumar, T., Mirle, V. R., Edobor, A., Fung, J. J., et al. (2021) · Matter · doi:10.1016/j.matt.2021.04.005 · Cited by 55
Self-citationKarami, K., Jamshidian, N., Hajiaghasi, A., & Amirghofran, Z. (2020) · New Journal of Chemistry · doi:10.1039/c9nj05847h · Cited by 54
Hypoxic Tumor Radiosensitization Using Engineered Probiotics
Huang, C., Wang, X., Liu, L., Jiang, W., Liu, W., Ma, W., & Zhao, H. (2021) · Advanced Healthcare Materials · doi:10.1002/adhm.202002207 · Cited by 54
Biologics and their delivery systems: Trends in myocardial infarction
Borrelli, M. A., Turnquist, H. R., & Little, S. R. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.03.014 · Cited by 56
Designs of metal-organic framework nanoparticles for protein delivery
Kai, M., Wang, S., Gao, W., & Zhang, L. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.07.056 · Cited by 54
Stimuli-responsive self-assembled dendrimers for oral protein delivery
Zeng, Z., Qi, D., Yang, L., Liu, J., Tang, Y., Chen, H., & Feng, X. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.10.049 · Cited by 53
The stimulation of GLP-1 secretion and delivery of GLP-1 agonists via nanostructured lipid carriers
Shrestha, N., Bouttefeux, O., Vanvarenberg, K., Lundquist, P., Cuñarro, J., Tovar, S. A., Khodus, G. R., Andersson, E., Keita, Å. V., Dieguez, C. G., et al. (2017) · Nanoscale · doi:10.1039/c7nr07736j · Cited by 51
Zheng, F., Wang, C., Meng, T., Zhang, Y., Zhang, P., Shen, Q., Zhang, Y., Zhang, J., Li, J., Min, Q., et al. (2019) · ACS Nano · doi:10.1021/acsnano.9b03424 · Cited by 52
Nanoparticle Therapy for Prostate Cancer: Overview and Perspectives
Zhang, J., Wang, L., You, X., Xian, T., Wu, J., & Pang, J. (2019) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026619666190125145836 · Cited by 52
Self-citationChen, J., He, H., Deng, C., Yin, L., & Zhong, Z. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.01.040 · Cited by 50
Nanotheranostics against COVID-19: From multivalent to immune-targeted materials
Hassanzadeh, P. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.08.060 · Cited by 48
Sikder, A., Chakraborty, S., Rajdev, P., Dey, P., & Ghosh, S. (2021) · Accounts of Chemical Research · doi:10.1021/acs.accounts.1c00195 · Cited by 47
Frizzell, H., Ohlsen, T. J., & Woodrow, K. A. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.09.043 · Cited by 48
Zhang, X., Zhang, R., Huang, J. C., Luo, M., Chen, X., Kang, Y., & Wu, J. (2019) · Journal of Materials Chemistry B · doi:10.1039/c9tb00181f · Cited by 48
Self-citationChen, S., Pang, H., Sun, J., & Li, K. (2023) · Materials Chemistry Frontiers · doi:10.1039/d3qm01020a · Cited by 47
Polymer-mediated protein/peptide therapeutic stabilization: Current progress and future directions
Sivasankaran, R. P., Snell, K., Kunkel, G. E., Georgiou, P. G., Puente, E. G., & Maynard, H. D. (2024) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2024.101867 · Cited by 54
Design and applications of protein delivery systems in nanomedicine and tissue engineering
Bizeau, J., & Mertz, D. (2020) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2020.102334 · Cited by 47
Leconet, W., Liu, H., Guo, M., Lamer-Déchamps, S. L., Molinier, C., Kim, S., Vrlinič, T., Oster, M., Liu, F., Navarro, V., et al. (2018) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-17-1138 · Cited by 46
Yao, P., Zhang, Y., Meng, H., Sun, H., & Zhong, Z. (2018) · Biomacromolecules · doi:10.1021/acs.biomac.8b01243 · Cited by 47
Lipid Nanoparticle Delivery of Small Proteins for Potent In Vivo RAS Inhibition
Haley, R. M., Chan, A., Billingsley, M. M., Gong, N., Padilla, M. S., Kim, E. H., Wang, H. H., Yin, D., Wangensteen, K. J., Tsourkas, A., et al. (2023) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.3c01501 · Cited by 43
Enzymes as key features in therapeutic cell mimicry
Itel, F., Schattling, P., Zhang, Y., & Städler, B. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.09.006 · Cited by 46
Metadata
- Authors
- Yu, M., Wu, J., Shi, J., & Farokhzad, O. C.
- Affiliations
- Brigham and Women's Hospital (US)
- Corresponding author
- Shi, Jinjun
- Farokhzad, Omid C.
- Venue
- Journal of Controlled Release
- Publisher
- Elsevier BV
- Published
- 2016-10
- Volume
- 240
- Pages
- 24-37
- ISSN
- 0168-3659 (ISSN-L)
- PMC
- PMC4833694
- OpenAlex
- W2173147935
- Cited by
- 410
- References
- 138
- Citations by year
- 2026: 29 · 2025: 47 · 2024: 34 · 2023: 40 · 2022: 44 · 2021: 65 · 2020: 47 · 2019: 48 · 2018: 26 · 2017: 21 · 2016: 9
- FWCI
- 1.13
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Controlled Release (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Rare & Special e-Zone (The Hong Kong University of Science and Technology) (submittedVersion)
- Funders
- National Institutes of Health (NIH) (EB015419, R00CA160350, U54-CA151884)
- Movember-Prostate Cancer Foundation (PCF)
- National Research Foundation of Korea (K1A1A2048701)
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Keywords
- protein delivery, nanotechnology, therapeutic proteins, nanoparticle drug delivery, systemic drug delivery, intracellular delivery, endosomal escape, membrane permeability, protein stability, immunogenicity, oral drug delivery, intranasal drug delivery, pulmonary drug delivery, transdermal drug delivery
- MeSH terms
- Animals, Humans, Proteins, Tissue Distribution, Drug Delivery Systems, Nanotechnology, Nanoparticles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
